We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AMC icon
326
AMC Entertainment Holdings
AMC
$2.61B
$914K 0.02%
+114,421
New +$3.39M
2023 Q3
0 quarters
IQV icon
327
IQVIA
IQV
$42.9B
$912K 0.02%
4,635
-11,000
-70% -$2.39M
2022 Q2
5 quarters
JAZZ icon
328
Jazz Pharmaceuticals
JAZZ
$14.3B
$908K 0.02%
7,014
-7,200
-51% -$959K
2022 Q1
6 quarters
ARDX icon
329
Ardelyx
ARDX
$829M
$898K 0.02%
+220,000
New +$858K
2023 Q3
0 quarters
SPY icon
330
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$894K 0.02%
110,000
-339,000
-76% -$151M
2019 Q4
15 quarters
HOG icon
331
PUT
Harley-Davidson
HOG
$2.83B
$875K 0.02%
+250,000
New +$8.7M
2023 Q3
0 quarters
W icon
332
Wayfair
W
$14.2B
$848K 0.02%
14,000
+4,000
+40% +$278K
2023 Q2
1 quarter
INFA icon
333
DELISTED
Informatica
INFA
$843K 0.02%
40,000
-85,000
-68% -$1.7M
2023 Q2
1 quarter
SCYX icon
334
SCYNEXIS
SCYX
$40.2M
$835K 0.01%
45,752
-2,500
-5% -$59.7K
2022 Q2
5 quarters
OSI icon
335
DELISTED
Osiris Acquisition Corp.
OSI
$832K 0.01%
80,570
– –
2021 Q3
8 quarters
BHAC icon
336
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$829K 0.01%
78,575
– –
2021 Q4
7 quarters
NKTR icon
337
Nektar Therapeutics
NKTR
$1.38B
$820K 0.01%
+91,750
New +$883K
2023 Q3
0 quarters
EWTX icon
338
Edgewise Therapeutics
EWTX
$4.24B
$801K 0.01%
139,858
– –
2022 Q2
5 quarters
THRD icon
339
DELISTED
Third Harmonic Bio
THRD
$799K 0.01%
+125,000
New +$764K
2023 Q3
0 quarters
QTRX icon
340
Quanterix
QTRX
$150M
$792K 0.01%
29,200
-4,800
-14% -$119K
2023 Q2
1 quarter
CRNX icon
341
DELISTED
Crinetics Pharmaceuticals
CRNX
$778K 0.01%
26,153
-30,000
-53% -$618K
2022 Q1
6 quarters
INTU icon
342
Intuit
INTU
$82.8B
$766K 0.01%
+1,500
New +$759K
2023 Q3
0 quarters
BCAB icon
343
DELISTED
BIOATLA INC
BCAB
$753K 0.01%
8,854
+800
+10% +$102K
2022 Q3
4 quarters
RZLT icon
344
Rezolute
RZLT
$471M
$736K 0.01%
557,307
+85,000
+18% +$139K
2023 Q1
2 quarters
CABA icon
345
Cabaletta Bio
CABA
$322M
$736K 0.01%
48,332
-33,000
-41% -$451K
2023 Q1
2 quarters
RIG icon
346
PUT
Transocean
RIG
$6.33B
$733K 0.01%
425,000
+25,000
+6% +$204K
2018 Q2
21 quarters
FUSN icon
347
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$714K 0.01%
274,568
– –
2022 Q3
4 quarters
ZM icon
348
Zoom
ZM
$28.8B
$699K 0.01%
10,000
-10,000
-50% -$694K
2023 Q1
2 quarters
SILK icon
349
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$697K 0.01%
46,528
-10,000
-18% -$208K
2022 Q1
6 quarters
RYTM icon
350
Rhythm Pharmaceuticals
RYTM
$6.2B
$688K 0.01%
+30,000
New +$672K
2023 Q3
0 quarters
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.